Skip to main content
. 2022 Feb 10;55(1):28–40. doi: 10.4143/crt.2021.1572

Table 5.

NTRK fusion transcripts detected from Seraseq, NTRK fusion reference

Fusion Supporting Reads counts
A (TSO 500) B (Lung Cancer Panel v3.0) C (OCA v3) D (OncoPanel v.4.3) E (TSO 500) F (OCA v3)
TPM3-NTRK1 234 44 39,211 NA 278 21,468
LMNA-NTRK1 324 29 - NA 426 -
IRF2BP2-NTRK1 188 35 112 NA 341 -
TFG-NTRK1 184 14 46,023 NA 174 114,933
SQSTM1-NTRK1 266 31 7,200 NA 418 33a)
AFAP1-NTRK2 133 53 17,371 NA 205 16a)
QKI-NTRK2 191 5 38,997 NA 229 1,611,524
TRIM24-NTRK2 163 - 5,791 NA 172 28a)
NACC2-NTRK2 168 - 16,377 NA 199 743,802
PAN3-NTRK2 152 32 NC NA 320 NC
ETV6-NTRK3 (E5N14) 147 70 28,094 NA 268 489
ETV6-NTRK3 (E5N15) 97 68 16,823 NA 224 1,955
ETV6-NTRK3 (E4N15) 153 18 1,024 NA 194 3a)
ETV6-NTRK3 (E4N14) 192 16 2,391 NA 212 4a)
BTBD1-NTRK3 100 58 40,086 NA 167 29,051

NTRK, neurotrophic receptor tyrosine kinase; OCA, Oncomine Comprehensive Assay; TSO, TruSight Oncology.

a)

Detected but filtered out because < 40 reads.